Global Sleep Apnea 麻豆原创 (By Products - Diagnostics & Therapeutics; By Region 鈥� North America-The US; Europe-The UK & Germany; Asia Pacific-China & India; Latin America) Outlook 2024

Publication ID:

ROC0718003

Publication Date:

July 31, 2018

Pages:

Publisher:

Rockville Research

Countries:

Global [1]

USD 1,100.00

Pharma & Healthcare [2]

Diagnostics [3]

Treatments [4]

Description:

Advent of auto-titrating CPAP machines has become a game-changer in sleep apnea devices market. The report 鈥淕lobal Sleep Apnea 麻豆原创 (By Products - Diagnostics & Therapeutics; By Region 鈥� North America-The US; Europe-The UK & Germany; Asia Pacific-China & India; Latin America) Outlook 2024鈥� provides information on the current scenario, market outlook of the global sleep apnea market with detailed analysis of market segments such as Diagnostics & Therapeutics. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe, Asia Pacific and Latin America. 麻豆原创 outlook for overall market as well as for various segments for aforementioned regions has been provided for the period 2018-24.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global sleep apnea market. The report has been segmented as following:-

麻豆原创 Segments
鈥� Diagnostics
鈥� Therapeutics

Geographical Coverage
鈥� North America - The US
鈥� Europe 鈥� The UK & Germany
鈥� Asia Pacific 鈥� China & India
鈥� Latin America

Companies Coverage
鈥� ResMed Inc.
鈥� Fisher & Paykel Healthcare
鈥� Philips Respironics
鈥� CareFusion

Sleep Apnea is a life-threatening sleep disorder characterized by abnormal pauses in breathing. It is caused by caused by either complete obstruction of the airway (obstructive apnea) or partial obstruction (obstructive hypopnea). There are three types of sleep apnea 鈥� obstructive, central, and mixed. Obstructive sleep apnea (OSA) is the most common type of sleep apnea. This condition is found to be more prevalent in elderly population and is often stimulated by lifestyle related chronic diseases such as cardiovascular diseases and obesity.

Growth of global sleep apnea devices market is primarily attributed to prevalence of sleep apnea, high incidence of lifestyle-related chronic diseases, increasing obesity, rising demand in emerging markets and increasing geriatric population. However, some of the factors restraining growth of the industry are stringent regulatory norms and high cost of devices.

The report 鈥淕lobal Sleep Apnea 麻豆原创 (By Products - Diagnostics & Therapeutics; By Region 鈥� North America-The US; Europe-The UK & Germany; Asia Pacific-China & India; Latin America) Outlook 2024鈥� provides information on the current scenario, market outlook of the global sleep apnea market with detailed analysis of market segments such as Diagnostics & Therapeutics. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe, Asia Pacific and Latin America. Future forecasts of sleep apnea treatment market overall and across various sub-segments has been provided till 2024, for all the geographies. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global sleep apnea market includes ResMed Inc., Fisher & Paykel Healthcare, Philips Respironics, CareFusion, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global as well as regional sleep apnea market.

Table Of Contents:

1. Executive Summary
2. Research Methodology
3. Sleep Apnea
3.1 Overview
3.2 Classification
3.2.1 Obstructive Sleep Apnea (OSA)
3.2.2 Mixed Sleep Apnea
3.2.3 Central Sleep Apnea (CSA)
3.3 Diagnosis & Treatment
3.3.1 Continuous Positive Airway Pressure (CPAP)
3.3.2 Other Airway Pressure Devices
3.3.3 Surgical Option
4. 麻豆原创 Analysis
4.1 麻豆原创 Sizing (Actual & Forecasted)
4.2 麻豆原创 Share Analysis
4.2.1 麻豆原创 Share by Type
4.2.2 麻豆原创 Share by Product
4.2.3 麻豆原创 Share by Region
5. 麻豆原创 Segmentation
5.1 Therapeutic Devices
5.1.1 Continuous Positive Airway Pressure (CPAP)
5.1.2 Oral Appliances
5.2 Diagnostic Devices
5.2.1 Polysomnography Devices (PSG)
6. Regional Analysis
6.1 North America
6.1.1 麻豆原创 Sizing (Actual & Forecasted)
6.1.2 The US
6.1.2.1 麻豆原创 Sizing (Actual & Forecasted)
6.1.2.2 麻豆原创 Share by Products
6.2 Europe
6.2.1 麻豆原创 Sizing (Actual & Forecasted)
6.2.2 Germany
6.2.2.1 麻豆原创 Sizing (Actual & Forecasted)
6.2.2.2 麻豆原创 Share by Type of Device
6.2.3 The UK
6.2.3.1 麻豆原创 Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 麻豆原创 Sizing (Actual & Forecasted)
6.3.2 China
6.3.2.1 麻豆原创 Sizing (Actual & Forecasted)
6.3.3 India
6.3.3.1 麻豆原创 Sizing (Actual & Forecasted)
6.4 Latin America
6.4.1 麻豆原创 Sizing (Actual & Forecasted)
7. 麻豆原创 Dynamics
7.1 Industry Trends & Developments
7.1.1 麻豆原创 Testing for Sleep Apnea
7.1.2 Advent of Auto-titrating CPAP
7.3 Growth Drivers
7.3.1 Prevalence of Sleep Apnea
7.3.2 Higher Incidence of Lifestyle-Related Chronic Diseases
7.3.3 Increasing Obesity
7.3.4 Rising Demand in Emerging 麻豆原创s
7.3.5 Increasing Geriatric Population
7.4 Challenges
7.4.1 High Cost of Device
7.4.2 Stringent Regulatory Norms
8. Competitive Landscape
8.1 Comparative Analysis
8.2 麻豆原创 Share Analysis
8.2.1 Global
8.2.2 Regional
9. Company Profiles
9.1 ResMed Inc.
9.2 Fisher & Paykel Healthcare
9.3 Philips Respironics
9.4 CareFusion

List of Tables
Table 1: Sleep Apnea Device Manufacturers Competitive Landscape
Table 2: Global Sleep Apnea 麻豆原创 Players Financial Analysis

List of Figures
Figure 1: Rockville Research 鈥� Research Methodology
Figure 2: Classification of Sleep Apnea
Figure 3: Components of Sleep Apnea Device
Figure 4: Global Sleep Apnea Devices 麻豆原创 Size by Value, 2016-22E (US$ Billions)
Figure 5: Global Sleep Apnea 麻豆原创 by Type (2017)
Figure 6: Global Sleep Apnea 麻豆原创 Share by Product (2018)
Figure 7: Global Sleep Apnea Devices 麻豆原创 Share by Region (2017)
Figure 8: OSA Prevalence by Nations (2017)
Figure 9: Global Sleep Apnea Therapeutic Devices 麻豆原创 Size by Value, 2017-24E (US$ Billions)
Figure 10: Global Sleep Apnea CPAP 麻豆原创 Size by Value, 2017-24E (US$ Millions)
Figure 11: Global Sleep Apnea Oral Appliances 麻豆原创 Size by Value, 2017-24E (US$ Millions)
Figure 12: Global Sleep Apnea Diagnostic Devices 麻豆原创 Size by Value, 2017-24E (US$ Billions)
Figure 13: Global Sleep Apnea 鈥� Polysomnography Devices (PSG) 麻豆原创 Size by Value, 2017-24E (US$ Millions)
Figure 14: North America Sleep Apnea 麻豆原创 Size by Value, 2017-24E (US$ Billions)
Figure 15: The US Sleep Apnea 麻豆原创 Size by Value, 2012-22E (US$ Millions)
Figure 16: The US Undiagnosed Obstructive Sleep Apnea Economic Costs (2016)
Figure 17: The US Sleep Apnea 麻豆原创 Share by Product (2017)
Figure 18: The US Sleep Apnea Therapeutics Device 麻豆原创 Share by Product (2017)
Figure 19: Europe Sleep Apnea 麻豆原创 Size by Value, 2017-24E (US$ Billions)
Figure 20: Germany Sleep Apnea 麻豆原创 Size by Value, 2012-22E (US$ Millions)
Figure 21: Germany Sleep Apnea 麻豆原创 Share by Type of Device (US$ Millions)
Figure 22: The UK Sleep Apnea 麻豆原创 Size by Value, 2017-24E (US$ Millions)
Figure 23: Asia Pacific Sleep Apnea 麻豆原创 Size by Value, 2017-24E (US$ Billions)
Figure 24: China Sleep Apnea 麻豆原创 Size by Value, 2017-24E (US$ Millions)
Figure 25: India Sleep Apnea 麻豆原创 Size by Value, 2017-24E (US$ Millions)
Figure 26: Latin America Sleep Apnea 麻豆原创 Size by Value, 2017-22E (US$ Billions)
Figure 27: Global Sleep Apnea Incidences, 2007-18 (Millions)
Figure 28: Prevalence of Sleep Apnea in Comorbidities (%)
Figure 29: Global Obese Population, 2012-18E (Millions)
Figure 30: Global Ageing Population, 2012-18E (Millions)
Figure 31: Global Sleep Apnea 麻豆原创 Share by Competitors (2018)
Figure 32: Asia Pacific Sleep Apnea 麻豆原创 Share by Competitors (2018)
Figure 33: ResMed Inc. Revenue by Business Segment (FY2017)
Figure 34: ResMed Inc. Net Sales, FY2013-FY2017 (US$ Billions)
Figure 35: Fisher & Paykel Healthcare Revenue by Business Segment (FY2017)
Figure 36: Fisher & Paykel Healthcare Net Sales, FY2013-FY2017 (US$ Billions)
Figure 37: Philips Respironics Revenue by Business Segment (FY2017)
Figure 38: Philips Respironics Net Sales, FY2013-FY2017 (US$ Billions)
Figure 39: CareFusion Revenue by Business Segment (FY2017)
Figure 40: CareFusion Net Sales, FY2013-FY2017 (US$ Billions)

Companies Mentioned:

ResMed Inc., Fisher & Paykel Healthcare, Philips Respironics, CareFusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.